Patents by Inventor Didier Hober

Didier Hober has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200060981
    Abstract: A combination of cationic nanoparticles and viruses and uses thereof. The use of nanoparticles for enhancing the infectious capacity of a live virus, preferably a non-enveloped live virus.
    Type: Application
    Filed: December 11, 2017
    Publication date: February 27, 2020
    Inventors: Didier Betbeder, Didier Hober
  • Patent number: 7534558
    Abstract: The present invention is related to an in vitro diagnostic assay of enteroviruses, based on the revealing of an immunologic reaction of antigen-antibody recognition type, using antigens or epitopes thereof that do not induce antiviral neutralising antibodies but induce “facilitating” antibodies which increase the viral infection.
    Type: Grant
    Filed: February 9, 2004
    Date of Patent: May 19, 2009
    Assignees: Universite de Lille 2 Droit Et Sante, Centre Hospitalier Regional Universitaire de Lille (Chru de Lille)
    Inventors: Wassim Chehadeh, Didier Hober, Ahmed Bouzidi
  • Publication number: 20060246420
    Abstract: The present invention is related to an in vitro diagnostic assay of enteroviruses, based on the revealing of an immunologic reaction of antigen-antibody recognition type, using antigens or epitopes thereof that do not induce antiviral neutralising antibodies but induce “facilitating” antibodies which increase the viral infection.
    Type: Application
    Filed: February 9, 2004
    Publication date: November 2, 2006
    Inventors: Wassim Chehadeh, Ahmed Bouzidi, Didier Hober